3D bioprinting company Allevi, formerly known as BioBots, is on a mission to make it easier for scientists and researchers to design and engineer 3D tissues. The company, which was founded four years ago, develops 3D bioprinters, software, and bioinks for the purposes of solving the most difficult biomedical problems that plague our world, such as disease and eliminating the organ waiting list.
But now, Allevi is preparing to take its 3D bioprinting work out of this world with a new initiative.
Ever since the space race began in the late 1950s and led to the first man on the moon, humanity has been working hard to conquer the vastness of outer space. 3D printing has helped in this quest, from sending astronauts into space for research and testing and allowing them to fabricate items in zero gravity and microgravity to creating tools, medical supplies, and even habitats in space. Space exploration has also led to the creation of such practical tools on Earth as joysticks, GPS devices, and thermometers. This last brings us back to the medical sector, and Allevi’s goal of 3D bioprinting replacement organs for humans.
“While we continue to understand the capabilities and constraints of 3d biofabrication here on Earth, the ability to explore cellular function in space could afford us novel discoveries of organ form and function that have never before been studied,” Allevi wrote.
Read the full article here.